Selection bias introduced by neuropsychological assessments

Canadian Journal of Neurological Sciences

Volumn 37, Issue 2, 2010, Pages 264-268

  Olson, Robert ^a,b,c   Parkinson, Maureen ^a   McKenzie, Michael ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DEXAMETHASONE; OPIATE;

ADULT; ARTICLE; BRAIN METASTASIS; COGNITION; COST; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG USE; FEASIBILITY STUDY; GLIOMA; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SCREENING TEST;

EID: 76649127071     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100010039     Document Type: Article

References (21)

1. Chang EJ, Wefel JS, Maor MH, Hassenbush III SJ, Mahajan A, Lang FF, et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurg. 2007;60(2): 277-284
2. Taphoorn MJB, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neuro. 2004;3(3):159-168
3. Herman MA, Tremont-Lukats I, Meyers CA, Trask DD, Froseth C, Renschler MF, et al. Neurocognitive and functional assessment of patients with brain metastases: a pilot study.Am J Clin Oncol. 2003;26(3):273-279
4. Mehta MP, Shapiro WR, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, et al. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol. 2002;20(16):3445-3453
5. Meyers CA, Hess KR, Yung WKA, Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol. 2000;18(3):646-650
6. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22(1):157-165
7. Meyers CA, Hess KR. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro-oncol. 2003;5(2):89-95.
8. Patel RR, Mehta MP. Targeted therapy for brain metastases: improving the therapeutic ratio. Clin Cancer Res. 2007;13(6): 1675-1683
9. Sherman AM, Jaeckle K, Meyers CA. Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease. Cancer. 2002;95(6):1311-1316
10. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol. 2006;24(8):1305-1309
11. Sherman AM, Jaeckle K, Meyers CA. Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease. Cancer. 2002;95(6):1311-1316
12. Meyers CA,Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol. 2003;21(19):3557-3558
13. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Ger Soc. 2005;53(4):695-699
14. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psych Res. 1975;12(3):189-198
15. Smith T, Gildeh N, Holmes C. The Montreal cognitive assessment: Validity and utility in a memory clinic setting. Can J Psychiat. 2007;52(5):329-332
16. Olson RA, Chhanabhai T, McKenzie M. Feasibility study of the Montreal cognitive assessment (MoCA) in patients with brain metastases. Support Care Cancer. 2008;16(11):1273-1278
17. Olson RA, Iverson G, Parkinson M, Carolan H, Ellwood A, McKenzie M. Investigation of cognitive screening measures in patients with brain tumors: diagnostic accuracy and correlation with quality of life. J Clin Oncol (Meeting Abstracts). 2009;27 (15S):e13000.
18. Weiss DJ, Kingsbury GG. Application of computerized adaptive testing to educational problems. J Educ Meas. 1984;21(4): 361-375
19. Meijer RR, Nering ML. Computerized adaptive testing: overview and introduction. App Psych Meas. 1999;23(3):187-194
20. Berk RA. An introduction to sample selection bias in sociological data. Am Sociol Rev. 1983;48(3):386-398
21. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323 (7303):42.